Overview
- After a chaotic session marked by last-minute wording changes, ACIP voted 6–3 to postpone Thursday’s decision and return Friday to consider reworked motions.
- Draft language would keep an automatic birth dose for infants of mothers who test positive and reaffirm it when status is unknown, while suggesting shared decision-making with a possible delay to at least two months for infants of mothers who test negative.
- Public-health experts and more than 30 Democratic lawmakers urged maintaining the universal birth dose, citing decades of safety monitoring, a 99% drop in pediatric hepatitis B since 1991, and modeling that predicts roughly 1,400 additional infections annually if the dose is delayed to two months.
- Any rollback could disrupt coverage and access because federal programs such as Vaccines for Children and many private insurers tie benefits to ACIP recommendations, potentially complicating birth-dose availability in hospitals.
- The meeting underscored concerns about process and politicization after RFK Jr. replaced prior members, with vaccine-critical testimony and stigmatizing claims about immigrants and gay men drawing criticism from physicians and former CDC leaders.